Education
About Us
Working with TipRanks
Follow Us
Orthofix Medical (OFIX)
NASDAQ:OFIX
Earnings Data
Report Date
May 12, 2026After Close (Confirmed)
Period Ending
2026 (Q1)Consensus EPS Forecast
-0.68Last Year’s EPS
-1.35Same Quarter Last Year
Moderate Buy
Based on 3 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call portrayed solid operational progress: targeted product launches (VIRATA), strong segment performance in BGT and Limb Reconstruction, distributor productivity gains (top 30 partners +25% YoY), margin expansion (Q4 adjusted EBITDA margin +230 bps) and strong Q4 free cash flow. Management acknowledged near-term headwinds from distributor transitions, biologics softness, a major-account price decrease and potential legal settlement exposure, and extended the long-range timeline by one year to fully realize channel benefits. Guidance for 2026 is constructive (mid-single digit revenue growth, improved EBITDA and positive full-year free cash flow excluding legal items) while some benefits are expected to be back‑half weighted.Company Guidance
Total Q4 Net Sales
Total global net sales of $218.6 million in Q4, up 3% pro forma (constant currency, excluding M6 disc).
Spine Fixation Growth and Channel Progress
Global Spine Fixation net sales grew 10% for the year (U.S. Spine +6% for the year and +5% in the quarter). Top 30 U.S. distributor partners grew net sales 25% year-over-year and 27% on a trailing 12-month basis; >75% of U.S. net sales now driven by these top 30 partners (up ~55 percentage points vs start of 2024).
Bone Growth Therapies Outperformance
BGT Q4 net sales $68.3 million, up 7% (more than double market growth of ~2–3%); increased utilization and higher prescribing velocity across spine fusion and fracture management.
Limb Reconstruction Momentum
U.S. Limb Reconstruction grew 8% in Q4 and 16% for the full year, driven by launches (TrueLok Elevate, FITBONE bone transport and trochanteric lengthening nails) and portfolio focus.
Enabling Technologies Traction (7D & Voyager)
7D FLASH navigation placements grew ~30% in 2025; Voyager earnout placements grew 30% and earnout customers are buying >50% more than committed volume, validating the earnout model and utilization.
Margin and EBITDA Expansion
Q4 pro forma non-GAAP adjusted gross margin of 71.4%; Q4 adjusted EBITDA $29.2 million (13.4% of net sales) with year-over-year margin expansion of ~230 basis points; eighth consecutive quarter of adjusted EBITDA growth.
Free Cash Flow and Cash Position
Strong Q4 free cash flow of $16.8 million; full-year free cash flow excluding M6-related restructuring was $3.1 million; ending cash balance $85.1 million.
2026 Guidance and Multi-Year Targets
2026 guidance: net sales $850–$860M (midpoint $855M, ~5.5% pro forma growth), adjusted EBITDA $95–$98M, positive full-year free cash flow (excluding legal settlements). Updated 2026–2028 targets: 6.5%–7.5% CAGR, mid‑teens adjusted EBITDA % by 2028, and positive FCF 2026–2028.
Pipeline and Product Launch Roadmap
Planned full market release of VIRATA Spinal Fixation System in H2 2026 (addressing a ~$2B U.S. pedicle screw market); >12 product launches/upgrades expected over next 18 months, including VIRATA MIS alpha launch and enhancements across Limb Reconstruction and BGT.
OFIX Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
OFIX Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Feb 24, 2026 | $13.59 | $12.75 | -6.18% |
Nov 04, 2025 | $16.06 | $14.87 | -7.41% |
Jun 30, 2025 | $11.09 | $11.15 | +0.54% |
May 06, 2025 | $13.54 | $12.06 | -10.93% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Orthofix Medical (OFIX) report earnings?
Orthofix Medical (OFIX) is schdueled to report earning on May 12, 2026, After Close (Confirmed).
What is Orthofix Medical (OFIX) earnings time?
Orthofix Medical (OFIX) earnings time is at May 12, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is OFIX EPS forecast?
OFIX EPS forecast for the fiscal quarter 2026 (Q1) is -0.68.